These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 10854607)
1. Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation. Davis HM; Carpenter DC; Stahl JM; Zhang W; Hynicka WP; Griswold DE J Immunol Methods; 2000 Jun; 240(1-2):125-32. PubMed ID: 10854607 [TBL] [Abstract][Full Text] [Related]
2. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors. Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological effects of a specific leukotriene B(4) receptor antagonist (VML 295) on blood leukocytes, cutaneous inflammation and epidermal proliferation. Seegers BA; Andriessen MP; van Hooijdonk CA; de Bakker ES; van Vlijmen-Willems IM; Parker GL; van Erp PE; van de Kerkhof PC Skin Pharmacol Appl Skin Physiol; 2000; 13(2):75-85. PubMed ID: 10754455 [TBL] [Abstract][Full Text] [Related]
5. The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys. Allen DL; Hoffman WP; Marder P; Matchett MR; Leiter PA; Abbott DL; Wolff RK J Pharmacol Exp Ther; 1996 Apr; 277(1):341-9. PubMed ID: 8613940 [TBL] [Abstract][Full Text] [Related]
6. Modulation of leukotriene B4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival. Stankova J; Turcotte S; Harris J; Rola-Pleszczynski M J Immunol; 2002 Apr; 168(7):3570-6. PubMed ID: 11907121 [TBL] [Abstract][Full Text] [Related]
7. Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis. Murray J; Ward C; O'Flaherty JT; Dransfield I; Haslett C; Chilvers ER; Rossi AG Br J Pharmacol; 2003 May; 139(2):388-98. PubMed ID: 12770944 [TBL] [Abstract][Full Text] [Related]
8. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111). van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114 [TBL] [Abstract][Full Text] [Related]
9. Neutrophils from burn patients are unable to increase the expression of CD11b/CD18 in response to inflammatory stimuli. Rodeberg DA; Bass RC; Alexander JW; Warden GD; Babcock GF J Leukoc Biol; 1997 May; 61(5):575-82. PubMed ID: 9129206 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist. Birke FW; Meade CJ; Anderskewitz R; Speck GA; Jennewein HM J Pharmacol Exp Ther; 2001 Apr; 297(1):458-66. PubMed ID: 11259574 [TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists. Lynn WA; Raetz CR; Qureshi N; Golenbock DT J Immunol; 1991 Nov; 147(9):3072-9. PubMed ID: 1717586 [TBL] [Abstract][Full Text] [Related]
12. Anticoagulant selection influences flow cytometric determination of CD11b upregulation in vivo and ex vivo. Repo H; Jansson SE; Leirisalo-Repo M J Immunol Methods; 1995 Sep; 185(1):65-79. PubMed ID: 7665901 [TBL] [Abstract][Full Text] [Related]